Tumor derived vasculogenesis in von Hippel-Lindau disease-associated tumors

Citations Over TimeTop 20% of 2014 papers

Abstract

von Hippel-Lindau disease (VHL) patients develop highly vascular tumors, including central nervous system hemangioblastomas. It has been hypothesized that the vascular nature of these tumors is the product of reactive angiogenesis. However, recent data indicate that VHL-associated hemangioblastoma neoplastic cells originate from embryologically-arrested hemangioblasts capable of blood and endothelial cell differentiation. To determine the origin of tumor vasculature in VHL-associated hemangioblastomas, we analyzed the vascular elements in tumors from VHL patients. We demonstrate that isolated vascular structures and blood vessels within VHL-associated hemangioblastomas are a result of tumor-derived vasculogenesis. Further, similar to hemangioblastomas, we demonstrate that other VHL-associated lesions possess vascular tissue of tumor origin and that tumor-derived endothelial cells emerge within implanted VHL deficient UMRC6 RCC murine xenografts. These findings further establish the embryologic, developmentally arrested, hemangioblast as the tumor cell of origin for VHL-associated hemangioblastomas and indicate that it is also the progenitor cell for other VHL-associated tumors.

Related Papers

• → Hemangioblastoma and mosaic von Hippel Lindau disease: rare presentation and review of the literature(2023)6 cited
• → Vasculogenesis and the Search for the Hemangioblast(2002)55 cited
• → Intraorbital optic nerve hemangioblastoma with von Hippel-Lindau disease(1982)43 cited
• → Cauda equinahemangioblastoma at L5 vertebral level related to von Hippel–Lindau disease(2011)7 cited
• → Human Vascular Progenitor Cells(2009)3 cited